T he vascular smooth muscle cell (VSMC) is a major component of the blood vessel wall and plays a critical role in the pathogenesis of atherosclerosis and vascular restenosis. 1 VSMCs undergo significant phenotype changes in response to inflammatory stimuli and mechanical injury associated with these disorders, which leads to aberrant proliferation and migration, apoptosis, and induction of matrix metalloproteinases (MMPs). 2 Phenotypic switching of VSMCs has also been reported in the context of aortic aneurysms. 3 Although atherosclerosis and aortic aneurysms share several common risk factors (eg, age, hypertension, smoking, and obesity), aortic aneurysms are distinguished from atherosclerosis by distinct mechanisms of disease progression (eg, prominent VSMC apoptosis, media degradation, and elastin destruction). 4 The role of VSMCs in aortic aneurysms is controversial, as they can contribute to inflammation and MMP production, 5 yet they are also capable of synthesizing matrix proteins. Yamanouchi et al 6 reported that treatment with a caspase inhibitor suppressed aneurysm formation in a mouse model, most likely by preventing VSMC apoptosis, suggesting that VSMCs can play a salutary role in aneurysm pathogenesis.
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Oxidative stress is pronounced in aortic aneurysm tissue and has been implicated in VSMC apoptosis and aneurysm pathogenesis. 7 VSMCs express various NADPH (nicotinamide adenine dinucleotide phosphate) oxidases isoforms that can regulate VSMC apoptosis, proliferation, migration, etc. 8 VSMC-specific overexpression of catalase, a peroxisomal enzyme that scavenges hydrogen peroxide formed through dismutation of NADPH oxidase-derived superoxide, protected against abdominal aortic aneurysm formation. 9 The transgenic mice with VSMC-specific overexpression of catalase exhibited less apoptosis, vascular inflammation, and MMP activity as compared with controls. This suggests that specifically protecting VSMC against oxidative stress has a salubrious effect on aortic aneurysm formation via several potential mechanisms.
Hypoxic conditions in aneurysmal tissues can also alter vascular function, potentially leading to apoptosis, inflammation, and weakening of the arterial wall. 10 Hypoxia in aortic aneurysm tissues has been reported to stimulate inflammation, resulting in local aortic wall weakening. 11 HIF-1α (hypoxiainducible factor), a master transcription factor induced by hypoxia, was reported to be markedly upregulated in human aneurysmal arteries, localized primarily in VSMCs and adventitia of aneurysmal tissues. 12 In mice, HIF-1α expression was also increased in tissues from elastase-induced abdominal aortic aneurysms. 13 Interestingly, increased HIF-1α in abdominal aortic aneurysm was reported to induce MMP expression in human VSMCs. 14 Furthermore, pharmacological inhibition or genetic silencing of HIF-1α was recently reported to attenuate abdominal aortic aneurysm formation by downregulating MMP-2 and MMP-9 expression and activity, 15, 16 suggesting that HIF-1α may positively regulate aortic aneurysm formation.
In this issue of ATVB, Imanishi et al 17 shed new light on the protective role of VSMC-specific HIF-1α for the maintenance of vascular wall integrity in the context of aortic aneurysms. Previously, they showed that VSMC-specific HIF-1α deficiency (VSMC HIF-1αKO ) inhibited angiotensin II-induced medial thickening via modulating VSMC hypertrophy and collagen I expression/fibrosis. 18 In the current study, using the VSMC HIF-1αKO mouse infused with angiotensin II plus β-aminopropionitrile, they report that deficiency of HIF-1α in VSMC exacerbates aortic aneurysm formation by suppressing elastin expression and cross-linking rather than by modulating MMP activity. Mechanistically, VSMC HIF-1αKO mice exhibited reduced expression of tropoelastin, a major source of elastin fiber, and lysyl oxidase, an elastin crosslinking enzyme in the vascular media. These findings suggest that endogenous HIF-1α in VSMC augments elastin fiber formation, thereby opposing matrix degradation and aortic wall weakening that leads to aneurysm formation (Figure) . The authors also reported excessive loss of VSMC in the VSMC HIF-1αKO mice; although apoptosis was not specifically quantified, they imply that it was mild. In vitro studies in VSMC from VSMC HIF-1αKO mice demonstrated reduced tropoelastin mRNA expression, suggesting a transcriptional regulatory mechanism linked to HIF-1α.
The findings of the present study are contrary to recent reports in angiotensin II-infused hyperlipidemic mice that HIF-1α induction exacerbated angiotensin II-induced abdominal aortic aneurysms by upregulating MMPs, whereas HIF-1α inhibition or gene silencing attenuated aneurysm formation or progression. 15, 16 These results likely reflect the divergent effects of HIF-1α in the various cell types that contribute to the pathogenesis of aortic aneurysms. In other words, the protective effect that HIF-1α plays in VSMC may be overshadowed by detrimental effects in other cell types that foster aneurysm disease. Other factors, such as the specific aneurysm model used, may also be important. In particular, the use of β-aminopropionitrile, which inhibits lysyl oxidase activity, in the study by Imanishi et al may have compounded the effect of VSMC HIF-1αKO to reduce lysyl oxidase expression in the blood vessel wall.
With advances in vascular biology research, the molecular and cellular mechanisms of aortic aneurysm formation have begun to be revealed. The role of aortic VSMC in the pathogenesis of aneurysms has received little attention to date, especially compared with the plethora of studies focused on inflammatory cells. The study by Imanishi et al adds to the growing body of data that VSMCs can protect against aortic aneurysm formation. Importantly, the authors provide proof of principle that HIF-1α-driven synthesis of matrix proteins by VSMC can actively oppose protease-mediated degradation and defend the integrity of the aortic wall.
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Figure.
Proposed role of HIF-1α (hypoxia-inducible factor) expression in vascular smooth muscle cell (VSMC) in aortic elastin fiber formation. HIF-1α deficiency in VSMC suppresses tropoelastin and lysyl oxidase (LOX) expression in the vascular media, thereby diminishing mature cross-linked elastin fiber formation. VSMC HIF-1αKO mice exhibited augmented aortic aneurysm formation when infused with AngII+BAPN. AngII indicates angiotensin II; and BAPN, β-aminopropionitrile.
